Listed

CEL Sci Corp: Form 10-Q for the period ended Dec 31, 2013

Filed with the SEC on Feb 10, 2014 and accepted by EDGAR at Feb 10, 2014, 21:16 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2013-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Research and development3 months2013-10-01 to 2013-12-31$4.0mus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2013-10-01 to 2013-12-31−$5.9mus-gaap:OperatingIncomeLoss
Interest expense3 months2013-10-01 to 2013-12-31$42.7kus-gaap:InterestExpense
Net income3 months2013-10-01 to 2013-12-31−$4.3mus-gaap:NetIncomeLoss
Diluted EPS3 months2013-10-01 to 2013-12-31−$0.15us-gaap:EarningsPerShareDiluted
Basic EPS3 months2013-10-01 to 2013-12-31−$0.11us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2013-10-01 to 2013-12-3148,215,919 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow3 months2013-10-01 to 2013-12-31−$5.9mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure3 months2013-10-01 to 2013-12-31$8.6kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2013-12-31$13.5mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2013-12-31$16.6mus-gaap:AssetsCurrent
Total assetsAt period end2013-12-31$24.8mus-gaap:Assets
Current liabilitiesAt period end2013-12-31$3.4mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2013-12-31$9.7mus-gaap:Liabilities
Shareholders' equityAt period end2013-12-31$15.1mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001354488-14-000595. Last ingested by Listed: Oct 24, 2026, 14:55 ET. Listed shows no prices and gives no investment advice.